This report, Vaccines 2009: Key Players, and Critical Trends in a Fast-Changing Industry), examines the market for vaccines used in humans to previous various types of disease.
Online PR News – 25-September-2009 – – The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions.
This report, Vaccines 2009: Key Players, and Critical Trends in a Fast-Changing Industry), examines the market for vaccines used in humans to previous various types of disease. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2008 period and forecasts are provided through 2013.
Since the last edition of this report:
Vaccine makers are now advertising directly to the public with growing DTC budgets. The report identifies the possible market impact of this new trend.
The economy has impacted vaccine sales with more people unable to make required out of pocket payments for vaccination.
New categories of vaccines, such as allergy vaccines, are becoming more prominent, and have been included in our forecasts.
Several major new products, including Wyeth's Prevnar 13, are on the horizon. The market impact of new products is discussed.
Two major mergers - Pfizer/Wyeth and Merck/Schering-Plough, will impact the industry and this is considered in our market analysis.
Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2008. Since last updated The World Market for Vaccines last year, new products and better than expected profits have transformed the vaccine marketplace. Continued sales of influenza vaccines and cervical cancer vaccines have provided a foundation for growth in the adult market. The competitive dynamics have changed with mergers, and many new products are on the way.
Kalorama Information's exhaustive research and analysis built from interviews with key decision makers in the market includes the following:
Review of Products in the Market
Current World Market Size for Pediatric and Adult Vaccines
Segmented Revenues and Forecasts to 2013 by Category
Over 45 Charts and Tables To Make Information Accessible
Discussion of The Current Economy and Vaccines, Immunization Refusal, Swine/Avian Flu and Other Pandemics, Delivery Sys and other Trends in the Vaccine Market
Important Vaccines and Immunization Schedules and Statistics
Profiles of 15 Key Vaccine Companies
Thorough Review of the Vaccine Pipeline and Possible Impact of New Products
Who are the main players in the vaccine market? What opportunities are available for pharmaceutical companies or investors from this market? What are the potential challenges vaccine competitors must deal with? What will be the impact of the first successful cancer product? What is the significance of at least one major acquisition to affect this industry? These questions and more are tackled in this report.
For more information, please visit :
Or email us at email@example.com or call +919272852585